Institution statistics - MEDICINE, HEALTH

BAYER AG - Germany 

Ranking results:

Past rankings:
Subject specific rankings are not yet available..
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 MEDICINE, HEALTH):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 14
As coordinator: 0
As participant: 14
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2011 0 8.841.009 0 2
2010 0 23.998.312 0 2
2007 0 12.571.628 529.882 2
2005 0 30.462.321 1.377.331 4
2004 0 11.359.754 449.585 2
2002 0 1.199.528 99.961 1
2001 0 1.710.000 427.500 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V15
VTT TECHNICAL RESEARCH CENTRE OF FINLAND9
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE7
JANSSEN PHARMACEUTICA NV7
NOVARTIS PHARMA7
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD7
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE6
PFIZER LIMITED6
ASTRAZENECA5
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG5
DEGUSSA5
ELI LILLY AND COMPANY LIMITED5
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE5
KATHOLIEKE UNIVERSITEIT LEUVEN5
NEDERLANDSE ORGANISATIE VOOR TOEGEPAST NATUURWETENSCHAPPELIJK ONDERZOEK TNO5
SANOFIAVENTIS5
TECHNISCHE UNIVERSITEIT EINDHOVEN5
UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND DUBLIN5
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS4
BASF SE4
CHARITE UNIVERSITAETSMEDIZIN BERLIN4
CONSIGLIO NAZIONALE DELLE RICERCHE4
DANMARKS TEKNISKE UNIVERSITET4
DECHEMA GESELLSCHAFT FUER CHEMISCHE TECHNIK UND BIOTECHNOLOGIE E V4
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT4
KAROLINSKA INSTITUTE4
RHEINISCH WESTFAELISCHE TECHNISCHE HOCHSCHULE AACHEN4
TAKEDA DEVELOPMENT CENTRE EUROPE4
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE4
UNIVERSITEIT GENT4
UPPSALA UNIVERSITET4
ASTRAZENECA UK LIMITED3
CENTRO RICERCHE FIAT S C P A3
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL3
COMMISSARIAT A L'ENERGIE ATOMIQUE3
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE3
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH3
EUROPEAN MOLECULAR BIOLOGY LABORATORY3
FORSCHUNGSZENTRUM JULICH3
INSTITUT DE RECHERCHES SERVIER3
INSTITUT FUER MIKROTECHNIK MAINZ3
INSTYTUT KATALIZY I FIZYKOCHEMII POWIERZCHNI POLSKA AKADEMIA NAUK3
INVITE3
KARLSRUHER INSTITUT FUER TECHNOLOGIE3
KING'S COLLEGE LONDON3
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV3
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN3
POLITECNICO DI MILANO3
SIB INSTITUT SUISSE DE BIOINFORMATIQUE3
SIEMENS3
STICHTING LYGATURE3
STIFTELSEN SINTEF3
TECHNISCHE UNIVERSITEIT DELFT3
TEVA PHARMACEUTICAL INDUSTRIES LIMITED3
THE UNIVERSITY OF MANCHESTER3
TTOPSTART BV3
UCB BIOPHARMA3
UNIVERSITA DEGLI STUDI DI GENOVA3
UNIVERSITAET PADERBORN3
UNIVERSITEIT UTRECHT3
UNIVERSITY OF COPENHAGEN3
UNIVERSITY OF DUNDEE3
UNIVERSITY OF NEWCASTLE UPON TYNE3
UNIVERSITY OF TAMPERE3
WEIZMANN INSTITUTE OF SCIENCE3
ABBVIE INC2
ACCIONA INFRAESTRUCTURAS2
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2
ASTELLAS PHARMA EUROPE BV2
BAYER SCHWEIZ2
BRITEST LBG2
CENTRE DE RECHERCHE PUBLIC DE LA SANTE2
CHRISTIAN DE DUVE INSTITUTE OF CELLULAR PATHOLOGY2
CLINIQUES UNIVERSITAIRES SAINTLUC2
COATEMA COATING MACHINERY2
COATEX SAS2
CONSORZIO INTERUNIVERSITARIO NAZIONALE PER LA SCIENZA E TECNOLOGIA DEI MATERIALI2
DELFT UNIVERSITY OF TECHNOLOGY2
DEUTSCHES KREBSFORSCHUNGSZENTRUM2
EBERHARD KARLS UNIVERSITAET TUEBINGEN2
EHRFELD MIKROTECHNIK BTS2
ENI2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS2
EUROPEAN CANCER PATIENT COALITION2
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL2
EUROPEAN PATIENTS' FORUM2
F HOFFMANNLA ROCHE2
FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS2
FRIEDRICHALEXANDERUNIVERSITAET ERLANGEN NUERNBERG2
GOETEBORGS UNIVERSITET2
GRUNENTHAL2
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT2
HEALTH AND SAFETY EXECUTIVE2
INSTITUT CURIE2
INSTITUT NATIONAL DE L'ENVIRONNEMENT INDUSTRIEL ET DES RISQUES2
INSTITUTO SUPERIOR TECNICO2
INTERUNIVERSITAIR MICRO ELECTRONICA CENTRUM VZW2
JOANNEUM RESEARCH FORSCHUNGSGESELLSCHAFT MBH2
JOHNSON MATTHEY PLC2
Constancy:

Total number of partners:975

Partner loyalty:
Frequent Partner: (> 2 projects): 268
Rare Partner: 707

Frequent / Rare Partner Ratio: 0.38

Diversity:

Categories:
Category:No:
INDUSTRY AND TECHNOLOGY21
RTD HORIZONTAL TOPICS19
SOCIAL AND ECONOMIC CONCERNS13
PROTECTING MAN AND HIS ENVIRON8
BIOLOGICAL SCIENCES7
ENERGY3
PHYSICAL AND EXACT SCIENCES2
MEASUREMENTS AND STANDARDS2

Project overview:

Start dateProjectacronymrolefundingpartners
2011-02-01Targeting the tumour microenvironment to improve pancreatic cancer prognosis EPC-TM-Netparticipant3.000.00017
2011-01-01Predicting individual response and resistance to VEGFR/mTOR pathway therapeutic intervention using biomarkers discovered through tumour functional genomics PREDICTparticipant5.841.00914
2010-11-01ASSET: Analysing and Striking the Sensitivities of Embryonal Tumours ASSETparticipant11.999.15619
2010-11-01ASSET: Analysing and Striking the Sensitivities of Embryonal Tumours ASSETparticipant11.999.15619
2007-04-01SME-led antibody glyco-engineering SAGEparticipant1.842.9279
2007-01-01Targeted delivery of nanomedicine MEDITRANSparticipant10.728.70133
2005-11-01Healthcare by biosensor measurements and networking CARE-MANparticipant11.449.30432
2005-11-01Epigenetic treatment of neoplastic disease EPITRONparticipant10.904.47414
2005-01-01Biosensors based on membrane organisation to replace animal testing BBMOparticipant443.87816
2005-01-01Optimisation and pre-validation of an in vitro test strategy for predicting human acute toxicity A-CUTE-TOXparticipant7.664.66536
2004-09-01Short-term in vitro assays for long-term toxicity PREDICTOMICSparticipant2.259.75413
2004-07-01Development of a novel approach in hazard and risk assessment or reproductive toxicity by a combination and application of in vitro, tissue and sensor technologies REPROTECTparticipant9.100.00033
2002-01-01Gene flow from transgenic plants: evaluation and biotechnology TRANSBACparticipant1.199.52812
2001-01-01Identification of critical rat testicular genes altered after fetal androgenic disruption by flutamide: use of dna microarray approach ENDISRUPTparticipant1.710.0004

Alias institution names:
  • BAYER
  • BAYER
  • BAYER
  • BAYER AG / BAYER HEALTH CARE
  • BAYER AG BAYER TECHNOLOGY SERVICES
  • BAYER AG ZWEIGNIEDERLASSUNG WITTERSWIL
  • BAYER AKTIENGESELLSCHAFT
  • BAYER ANIMAL HEALTH
  • BAYER BIOSCIENCE NV
  • BAYER CROPSCIENCE
  • BAYER CROPSCIENCE
  • BAYER CROPSCIENCE BIOLOGICS
  • BAYER CROPSCIENCE NV
  • BAYER HEALTH CARE
  • BAYER INNOVATION
  • BAYER MATERIALSCIENCE
  • BAYER PHARMA
  • BAYER PUBLIC LIMITED COMPANY
  • BAYER SAS
  • BAYER SCHERING PHARMA
  • BAYER SCHERING PHARMA AG GROUP
  • BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
  • BAYER SCHWEIZ
  • BAYER TECHNOLOGY SERVICES
  • BAYER WOOD TECHNOLOGIES

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum